Perceptions of a Gender-Neutral Approach to Human Papillomavirus (HPV) Vaccination in Cameroon: A Qualitative Study
Iliassu, S.; Mbanga, C.; Ngenge, M. B.; Ndoula, S.; Njoh, A. A.; Griffith, B. C.; Patel, S.; Singh, N.; Nebongo, D.; Bieme-Ndi, E. C.; Derrick, N. S.; Mngemane, S.; Ajayi, T.; Zultak, L. A.; Saidu, Y.
Show abstract
Cameroons Expanded Program on Immunization (EPI) introduced the HPV vaccine into the routine immunization schedule in Cameroon in October 2020. However, HPV vaccine coverage has remained low, reaching only 20% by December 2022. In response, a gender-neutral vaccination (GNV) approach was adopted and implemented from January 2023 to increase acceptance, reduce stigma, and improve vaccine coverage. This study aimed to assess the perceptions of key immunization stakeholders in Cameroon on the GNV approach to HPV vaccination. A cross-sectional study was conducted from June to September 2024 using an in-depth and semi-structured interviews to explore the perspectives of key stakeholders (policymakers, community leaders, and parents of girls aged 9-13 years) across three regions (South-West, North, and Centre) and the central level. Data was analyzed using traditional content analysis, via manual and NVivo coding to identify key themes. The research team ensured reliability through consensus discussions, and key quotes illustrating central findings were identified. A total of 51 participants were interviewed. Participants observed that the inclusion of boys in the HPV vaccination program contributed to a positive shift in community perceptions, dispelled misconceptions, and enhanced overall vaccine acceptance. However, challenges related to limited resources, lingering misinformation, and hesitancy from parents, religious leaders, and healthcare workers hindered the effective implementation of the GNV approach. Participants emphasized the need for improved partnerships, sensitization strategies, integration with existing health programs, and sustained funding to enhance community understanding and increase vaccination uptake. Overall, stakeholders viewed the GNV approach as effective for improving HPV vaccine acceptability and promoting equity, but emphasized the need for continuous investments and stronger community engagement to address challenges like limited resources, misinformation, and hesitancy.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV: Qualitative insights from Eswatini, Malawi, and Uganda 96%
- High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study 96%
- COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines 96%
Similar papers in this journal
Similar papers in this journal
- “ We don’t routinely check vaccination background in adults” : A national qualitative study of barriers and facilitators to vaccine delivery and uptake in adult migrants through UK primary care 95%
- Exploring intersectional determinants of, and interventions for, low uptake of human papillomavirus vaccine in Sub-Saharan Africa: A scoping review protocol 95%
- Challenges and facilitators in pathways to cancer diagnosis in Southern Africa: A qualitative study 94%
Similar papers in this journal
- Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol 95%
- Exploration of the Social Determinants of Diarrhoea, Rotavirus Vaccine Uptake, and Vaccine ‘Fatigue’ in Ethiopia, Kenya, and Malawi 94%
- COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: a mixed-methods study 94%
Similar papers in this journal
- Community-based Case Studies of Vaccine Hesitancy and the COVID-19 Response in South Africa; The VaxScenes Study 95%
- “Where the truth really lies”: Listening to voices from African American communities in the Southern States about COVID-19 vaccine information and communication 95%
- Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.